The global Candidiasis Market Growth Accelerated by Rising Prevalence of Candidiasis Infections
Candidiasis commonly known as thrush is a fungal infection caused by yeasts that belongs to the Candida genus. It can infect the skin, mouth, throat, esophagus, or genital area. candidiasis infections pose a significant economic burden on healthcare systems worldwide owing to the high costs associated with treatment of recurrent infections. Candidiasis treatment market comprises antifungal drugs such as azoles, echinocandins, and polyenes which help cure infections faster with lower chances of recurrence. The global Candidiasis Market is estimated to be valued at US$ 984.8 Mn in 2023 and is expected to exhibit a CAGR of 8.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The rising prevalence of associated risk factors such as diabetes, use of antibiotics, and immunosuppressive conditions are expected to drive the growth of Candidiasis Market size during the forecast period. According to the Centers ...